Title : Meta-analysis of randomized controlled trials comparing telmisartan with losartan in the treatment of patients with hypertension.

Pub. Date : 2008 May

PMID : 18437146






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Use of telmisartan resulted in a significant reduction in clinic DBP (weighted mean difference 1.52, 95% confidence interval (CI) 0.85-2.19) and SBP (2.77, 1.90-3.63) when compared with losartan. Telmisartan selenium binding protein 1 Homo sapiens
2 There was also a significant reduction in 24-h mean ambulatory DBP (2.49, 0.56-4.42) and SBP (2.47, 0.40-4.55) with telmisartan as compared to losartan. Telmisartan selenium binding protein 1 Homo sapiens
3 There was also a significant increase in therapeutic response of DBP (relative risk (RR) 1.14, 1.04-1.23) and SBP response (1.10, 1.01-1.20) with telmisartan as compared to losartan. Telmisartan selenium binding protein 1 Homo sapiens